PLX
Protalix Biotherapeutics Inc
AMEX: PLX · HEALTHCARE · BIOTECHNOLOGY
$2.56
-1.16% today
Updated 2026-11-02
Market cap
$208.68M
P/E ratio
11.26
P/S ratio
2.59x
EPS (TTM)
$0.23
Dividend yield
—
52W range
$2 – $3
Volume
0.8M
Protalix Biotherapeutics Inc (PLX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.56
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 11.26x (capped 25x) · Margin: 23.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.